Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11970544 Antibodies

Patent 11970544 was granted and assigned to Genmab A/S on April, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
‌
Genmab A/S
0
Date Filed
June 21, 2021
0
Date of Patent
April 30, 2024
0
Patent Applicant
‌
Genmab A/S
0
Patent Application Number
17353087
0
Patent Citations
‌
US Patent 10465006 Humanized or chimeric CD3 antibodies
0
‌
US Patent 10590206 Inert format
0
‌
US Patent 10597464 Heterodimeric antibody Fc-containing proteins and methods for production thereof
0
‌
US Patent 10906991 Bispecific antibodies and methods for production thereof
0
‌
US Patent 11130819 Antibodies
0
‌
US Patent 11008399 Antibodies
0
‌
US Patent 9150663 Heterodimeric antibody Fc-containing proteins and methods for production thereof
0
‌
US Patent 9212230 Bispecific antibodies and methods for production thereof
0
‌
US Patent 10344050 Production of heterodimeric proteins
0
‌
US Patent 10407501 Humanized or chimeric CD3 antibodies
0
•••
Patent Inventor Names
Paul Parren
0
Sjeng Horbach
0
Dennis Verzijl
0
Patrick Engelberts
0
Rik Rademaker
0
Bart E. C. G. De Goeij
0
David Satijn
0
Edward N. Van Den Brink
0
Kristel Kemper
0
Esther C. W. Breij
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11970544
0
Patent Primary Examiner
‌
Jessica H Roark
0

Find more entities like US Patent 11970544 Antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo